Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             101 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study Arai, Takayuki

9 p. 1467-1476
artikel
2 Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence Tate, Shinichi

9 p. 1726-1735
artikel
3 Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data Choi, Hyo Geun

9 p. 1752-1758
artikel
4 APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients Takao, Misato

9 p. 1661-1670
artikel
5 Association between chronic kidney disease and mortality in stage IV cancer Ishii, Taisuke

9 p. 1587-1595
artikel
6 Association of gene mutations with clinicopathologic features in patients with external auditory canal squamous cell carcinoma Morita, Shinya

9 p. 1394-1403
artikel
7 Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male population Han, Peng
2019
9 p. 1042-1048
artikel
8 Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer Fukuokaya, Wataru

9 p. 1695-1703
artikel
9 CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib Kato, Ryoji

9 p. 1628-1639
artikel
10 Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Okonogi, Noriyuki
2019
9 p. 1143-1150
artikel
11 Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells Hayano, Azusa
2019
9 p. 1020-1029
artikel
12 Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors Aoki, Yu

9 p. 1413-1420
artikel
13 Chemoradiotherapy for high-risk stage II laryngeal cancer Hamauchi, Satoshi

9 p. 1596-1603
artikel
14 Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan Nomura, Hidetaka
2019
9 p. 1105-1110
artikel
15 Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer Miyajima, Keiichiro

9 p. 1200-1206
artikel
16 Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab Suzuki, Kotaro

9 p. 1678-1686
artikel
17 Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer Wang, Bo

9 p. 1147-1157
artikel
18 Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy Collà Ruvolo , Claudia

9 p. 1707-1713
artikel
19 Comparison of intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy at a medium-sized facility Iwata, Takehiro

9 p. 1714-1721
artikel
20 Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer Kitamura, Kei

9 p. 1671-1678
artikel
21 Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials Kawakami, Hisato

9 p. 1635-1643
artikel
22 Correction to: Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome Tamura, Kazuo
2019
9 p. 1012
artikel
23 Correction to: Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching Matsunaga, Yutaro

9 p. 1775
artikel
24 Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib Tamura, Kazuo
2019
9 p. 1169
artikel
25 Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) Hishiki, Tomoro

9 p. 1744-1745
artikel
26 Correction to: Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group Shigeta, Shogo

9 p. 1516
artikel
27 Current clinical topics of Lynch syndrome Tanakaya, Kohji
2018
9 p. 1013-1019
artikel
28 Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care Hirata, Koichi
2019
9 p. 1161-1168
artikel
29 Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan Uneno, Yu

9 p. 1529-1542
artikel
30 Development of a novel apoptosis-based tumor regression grade to assess the efficacy of preoperative chemoradiotherapy for rectal cancer: a retrospective single-center study Ozaki, Kosuke

9 p. 1679-1688
artikel
31 Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer? Hasegawa, Tetsuya
2019
9 p. 1129-1136
artikel
32 Effect of a web-based fertility preservation training program for medical professionals in Japan Ono, Masanori

9 p. 1112-1120
artikel
33 Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients Ruanglertboon, Warit

9 p. 1672-1677
artikel
34 Effect of SIB-IMRT-based selective dose escalation of local tumor on the prognosis of patients with esophageal cancer Gao, Hong-Mei

9 p. 1640-1649
artikel
35 Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial Chi, Yihebali

9 p. 1611-1618
artikel
36 Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma Goto, Hideki

9 p. 1736-1743
artikel
37 Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis XiaoHong, Chen
2019
9 p. 1151-1160
artikel
38 Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis Zang, Shizhao
2019
9 p. 1049-1060
artikel
39 Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic Aznab, Mozaffar

9 p. 1581-1586
artikel
40 External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer Fukagawa, Eri

9 p. 1736-1744
artikel
41 FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma Zhou, Fengrui

9 p. 1612-1623
artikel
42 Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study Bun, Seiko
2019
9 p. 1111-1118
artikel
43 Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome Tamura, Kazuo

9 p. 999-1011
artikel
44 Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer Nara, Katsuhiko

9 p. 1207-1217
artikel
45 High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma Yamamichi, Gaku
2019
9 p. 1075-1080
artikel
46 High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT Chen, Tzu-Ju

9 p. 1689-1697
artikel
47 History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer Nara, Katsuhiko

9 p. 1759-1766
artikel
48 Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis Yang, Ke
2019
9 p. 1030-1041
artikel
49 Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan Kimura, Tomokazu

9 p. 1687-1694
artikel
50 Impact of osteopenia and neutropenia in patients with colorectal cancer treated with FOLFOXIRI: a retrospective cohort study Nakao, Toshihiro

9 p. 1439-1449
artikel
51 Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy Tsukagoshi, Mariko

9 p. 1698-1706
artikel
52 Impact of time to first relapse on long-term outcome in adult retroperitoneal sarcoma patients after radical resection Guan, Huajie

9 p. 1487-1498
artikel
53 Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice Sugiyama, Toru

9 p. 1517-1528
artikel
54 Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger Makabe, Takeshi

9 p. 1767-1774
artikel
55 Incidence, trend and risk factors associated with suicide among patients with malignant intracranial tumors: a surveillance, epidemiology, and end results analysis Zhou, Zhihuan

9 p. 1386-1393
artikel
56 Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer Aoki, Yoichi

9 p. 1499-1506
artikel
57 Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis Katayama, Satoshi

9 p. 1587-1599
artikel
58 Introduction: Lynch syndrome—its molecular mechanism and current topics Tomita, Naohiro
2018
9 p. 997-998
artikel
59 Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort Ito, Katsuhiro
2019
9 p. 1081-1088
artikel
60 LINC00943 is correlated with gastric cancer and regulates cancer cell proliferation and chemosensitivity via hsa-miR-101-3p Xu, Yan

9 p. 1650-1660
artikel
61 Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis Ozeki, Yusuke

9 p. 1459-1466
artikel
62 Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy Guo, Feilong

9 p. 1158-1165
artikel
63 Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab Nagaoka, Tomoyuki

9 p. 1191-1199
artikel
64 Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas Liang, Xiaohong
2019
9 p. 1061-1068
artikel
65 Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy Matsumoto, Kazuhiro

9 p. 1722-1728
artikel
66 Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review Manatakis, Dimitrios K .

9 p. 1570-1580
artikel
67 Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses Ohyama, Chikara
2019
9 p. 1089-1098
artikel
68 Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance Kato, Mayumi Kobayashi

9 p. 1663-1671
artikel
69 Oncological safety of reconstruction with autologous fat grafting in breast cancer patients: a systematic review and meta-analysis Sun, Jiale

9 p. 1379-1385
artikel
70 Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106) Yukami, Hiroki

9 p. 1176-1182
artikel
71 Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients Ota, Mitsuhiko

9 p. 1166-1175
artikel
72 Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy Hashimoto, Takeshi

9 p. 1704-1710
artikel
73 Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients Kanehira, Mitsugu
2019
9 p. 1099-1104
artikel
74 Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy Taniguchi, Tomoki

9 p. 1711-1717
artikel
75 Preoperative nutrition and exercise intervention in frailty patients with gastric cancer undergoing gastrectomy Wada, Yuma

9 p. 1421-1427
artikel
76 Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study Sato, Shingo

9 p. 1227-1235
artikel
77 Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum Ito, Takahiko

9 p. 1450-1458
artikel
78 Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer Macchi, Lorenzo

9 p. 1428-1438
artikel
79 Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents Miyake, Hideaki

9 p. 1745-1751
artikel
80 Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients Takamatsu, Kimiharu
2019
9 p. 1069-1074
artikel
81 Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy Aydh, Abdulmajeed

9 p. 1729-1735
artikel
82 Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis Yamazaki, Masae

9 p. 1129-1138
artikel
83 Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel Narita, Shintaro

9 p. 1477-1486
artikel
84 Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance Tahara, Makoto

9 p. 1619-1627
artikel
85 Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group Shigeta, Shogo

9 p. 1507-1515
artikel
86 Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort Signoroni, Stefano

9 p. 1644-1652
artikel
87 Role of the DEK oncogene in the development of squamous cell carcinoma Ishida, Kazuhisa

9 p. 1563-1569
artikel
88 Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer Saito, Yoshitaka

9 p. 1183-1190
artikel
89 Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer Chao, Xue

9 p. 1653-1662
artikel
90 Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab Hoshi, Yuta

9 p. 1139-1146
artikel
91 Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy Shimada, Kyoko

9 p. 1718-1725
artikel
92 Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405) Haratake, Naoki

9 p. 1404-1412
artikel
93 The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis Xu, Ke

9 p. 1624-1634
artikel
94 The efficacy of albumin–globulin ratio to predict prognosis in cancer patients Roberts, Will S.

9 p. 1101-1111
artikel
95 The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review Olthof, Ester P.

9 p. 1600-1610
artikel
96 The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma Kano, Satoshi

9 p. 1121-1128
artikel
97 The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis Liang, Lei

9 p. 1575-1586
artikel
98 Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy Tsushima, Nayuta

9 p. 1218-1226
artikel
99 Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis Tanaka, Yusuke
2019
9 p. 1137-1142
artikel
100 Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapy Tsuruoka, Shintaro
2019
9 p. 1119-1128
artikel
101 Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining Ikeda, Yusuke

9 p. 1604-1611
artikel
                             101 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland